ProstaglandinF2α (PGF2α) drives luteolysis and smooth muscle contraction by activating the FP receptor. Bimatoprost methylester is a lipophilic analog of 17-phenyltrinor PGF2α, a potent agonist for the FP receptor. 17-phenyltrinor PGF2α binds the FP receptor on ovine luteal cells with a relative potency of 756% compared to that of PGF2α. Esters of PGs serve as prodrugs, as they are efficiently hydrolyzed in certain tissues to generate the bioactive free acid.
ProstaglandinF2α (PGF2α), acting through the FP receptor, causes smooth muscle contraction and exhibits potent luteolytic activity. 17-trifluoromethylphenyltrinor PGF2α is an analog of PGF2α that shares the meta-trifluoromethyl group of travoprost with the 17-phenyltrinor modification of latanoprost. It is anticipated to be a potent and selective agonist of the FP receptor, with potential applications in glaucoma and luteolysis. 17-trifluoromethylphenyltrinor PGF2α methylester is a lipophilic analog of 17-trifluoromethylphenyltrinor PGF2α. Methylesters of PGs serve as prodrugs, as they are efficiently hydrolyzed in certain tissues to generate the bioactive free acid.